Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

170.47 +3.56 (+2.13%)
Streaming Delayed Price Updated: 3:44 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More ↗
Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months 
Via Benzinga
Topics Cannabis
News headline image
Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report ↗
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale. 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy in October ↗
Growth catalysts lie ahead for both of these players. 
Via The Motley Fool
News headline image
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023 ↗
These highly profitable, time-tested companies can deliver for their shareholders in any economic climate. 
Via The Motley Fool
News headline image
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗
An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound. 
Via The Motley Fool
Topics Stocks
News headline image
Where Jazz Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
Expert Ratings for Jazz Pharmaceuticals ↗
 
Via Benzinga
News headline image
Where Jazz Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗
 
Via Benzinga
News headline image
3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall ↗
The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar. 
Via InvestorPlace
Topics Cannabis
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,... 
Via FinancialNewsMedia
News headline image
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall ↗
Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy. 
Via InvestorPlace
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Via Investor Brand Network
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom ↗
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed. 
Via InvestorPlace
Topics Cannabis
News headline image
Cannabis Industry Changes As Marijuana Rescheduling Looms ↗
As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top... 
Via Benzinga
Topics Cannabis
News headline image
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years ↗
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035. 
Via Benzinga
News headline image
Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030 ↗
These two businesses may be sound, but generating returns in this industry has been tough, with no light at the end of the tunnel. 
Via The Motley Fool
Topics Cannabis
News headline image
Epidiolex Counterpart Debuts In Brazil's Cannabis Market As Its Maker Eyes TSX IPO ↗
Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância... 
Via Benzinga
Topics Cannabis
News headline image
Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target ↗
Cantor Fitzgerald analyst Charles C. 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From August 11, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues? ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year. 
Via Benzinga
News headline image
3 Biotech Stocks You’ll Regret Not Buying Soon ↗
These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors. 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
GOP Rep. Blasts FDA Over CBD Inaction During Historic Hearing: The Agency Wants More Money To Do Its Job ↗
For the first time, Congress officially addressed the impact of the U.S. Food and Drug Administration’s (FDA) inaction regarding the regulations of CBD products. 
Via Benzinga
News headline image
FDA, Get It Done! Says Senator In Bipartisan Push To Regulate CBD Products Prior To Committee Hearing ↗
A bipartisan group of U.S. lawmakers reintroduceda measure on Wednesdaythat aims to secure theFood and Drug ... 
Via Benzinga
News headline image
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group ↗
Is the battle for medical marijuana legalization in North Carolina over for this year? Some groups say yes, some say know, here is what happened. 
Via Benzinga
News headline image
4 Unequaled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗
Bargains are hiding in plain sight with the Nasdaq Composite still well below its November 2021 record-closing high. 
Via The Motley Fool
News headline image
Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful' ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has filed suit against the FDA for approving Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) Lumryz (sodium oxybate extended-release) for cataplexy or excessive day 
Via Benzinga
News headline image
10 Cannabis Stocks That Could Go Sky High In 2023 ↗
With cannabis legalization gaining momentum, investing in cannabis presents a lucrative opportunity. Investors may want to explore cannabis stocks to enhance their portfolios. Here are the top 10... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.